These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7011729)

  • 1. Receptor binding properties and biologic activity in vitro of biosynthetic human insulin.
    Keefer LM; Piron MA; De Meyts P
    Diabetes Care; 1981; 4(2):209-14. PubMed ID: 7011729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potency of biosynthetic human insulin determined in vitro.
    Fussgaenger RD; Ditschuneit HH; Martini H; Wiebauer-De Lenardis H; Etzrodt H; Thun C; Ditschuneit H; Pfeiffer EF; Enzmann F
    Diabetes Care; 1981; 4(2):228-34. PubMed ID: 7011733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biologic potency and binding affinity of biosynthetic human insulin in isolated rat adipocytes.
    Sonne O; Foley JE; Gliemann J
    Diabetes Care; 1981; 4(2):250-1. PubMed ID: 7011738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human insulin prepared by recombinant DNA techniques and native human insulin interact identically with insulin receptors.
    Keefer LM; Piron MA; De Meyts P
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1391-5. PubMed ID: 7015337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin binding, biologic activity, and metabolism of biosynthetic human insulin.
    Olefsky JM
    Diabetes Care; 1981; 4(2):244-7. PubMed ID: 7011736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro studies on biosynthetic human insulin: an overview.
    De Meyts P; Halban P; Hepp KD
    Diabetes Care; 1981; 4(2):144-6. PubMed ID: 7011715
    [No Abstract]   [Full Text] [Related]  

  • 7. Receptor binding and effect of biosynthetic human insulin on 2-deoxyglucose transport.
    Wieringa T; van Putten JP; Van Dijk-Besling M; Krans HM
    Diabetes Care; 1981; 4(2):254-6. PubMed ID: 7011740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of biosynthetic human proinsulin. Receptor binding and biologic potency of proinsulin and insulin in isolated rat adipocytes.
    Peavy DE; Abram JD; Frank BH; Duckworth WC
    Diabetes; 1984 Nov; 33(11):1062-7. PubMed ID: 6389225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pancreatic human and biosynthetic human insulin with respect to their action on adipocytes and chick embryo fibroblasts.
    Zapf J; Froesch ER
    Diabetes Care; 1981; 4(2):257-9. PubMed ID: 7011741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internalization of 125I-insulin by IM-9 cultured human lymphocytes: a comparison between A14-monoiodo-pork and biosynthetic human insulin.
    Carpentier JL; Halban PA; Renold AE; Orci L
    Diabetes Care; 1981; 4(2):220-2. PubMed ID: 7011731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor binding and biologic activity of biosynthetic human insulin and mini-proinsulin produced by recombinant gene technology.
    Kobayashi M; Sasaoka T; Sugibayashi M; Iwanishi M; Shigeta Y
    Diabetes Res Clin Pract; 1989 Jun; 7(1):25-8. PubMed ID: 2666066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin binding and response to insulin of adipocytes from thyroxine-treated rats.
    Heise E; Joost HG; Hasselblatt A
    Endocrinology; 1982 Mar; 110(3):955-60. PubMed ID: 7035151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of biosynthetic human insulin to human antibodies and receptors.
    Petersen KG; Schlüter K; Steinhilber S; Kerp L
    Diabetes Care; 1981; 4(2):248-9. PubMed ID: 7011737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An insulin analogue possessing higher in vitro biological activity than receptor binding affinity. [21-Proline-B]insulin.
    Schwartz GP; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1983 Sep; 22(19):4561-7. PubMed ID: 6354263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation, receptor binding affinity and biological potency of monoiodoinsulin in isolated rat fat cells.
    Gammeltoft S; Vinten J; Gliemann J; Linde S
    Horm Metab Res; 1977 May; 9(3):186-9. PubMed ID: 885469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor binding of biosynthetic human insulin on isolated pig hepatocytes.
    Gammeltoft S
    Diabetes Care; 1981; 4(2):235-7. PubMed ID: 7011734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hagfish insulin: the discrepancy between binding affinity and biologic activity.
    Emdin SO; Sonne O; Gliemann J
    Diabetes; 1980 Apr; 29(4):301-3. PubMed ID: 6987119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The insulin receptor and insulin of the Atlantic hagfish. Extraordinary conservation of binding specificity and negative cooperativity in the most primitive vertebrate.
    Muggeo M; Van Obberghen E; Kahn CR; Roth J; Ginsberg BH; De Meyts BH; Emdin SO; Falkmer S
    Diabetes; 1979 Mar; 28(3):175-81. PubMed ID: 446902
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin binding and insulin action in rat fat cells after adrenalectomy.
    Häring H; Calle C; Bug A; Renner R; Hepp KD; Kemmler W
    Diabetologia; 1980 Oct; 19(4):379-85. PubMed ID: 7000600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic activity and receptor binding properties of biosynthetic human insulin in isolated rat hepatocytes and mouse soleus muscle in vitro.
    Fehlmann M; Le Marchand-Brustel Y; Dolais-Kitabgi J; Morin O; Freychet P
    Diabetes Care; 1981; 4(2):223-7. PubMed ID: 7011732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.